PK

Paul E. G. Kristjansen

SA Santaris Pharma A/S: 5 patents #10 of 54Top 20%
EP Enzon Pharmaceuticals: 4 patents #8 of 41Top 20%
HA H. Lundbeck A/S: 2 patents #217 of 451Top 50%
KU Københavns Universitet: 1 patents #30 of 76Top 40%
Overall (All Time): #541,343 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12421303 Agents, uses and methods for the treatment of synucleinopathy Pekka Kallunki, Jeffrey B. Stavenhagen 2025-09-23
10889635 Agents, uses and methods for the treatment of synucleinopathy Pekka Kallunki 2021-01-12
8785617 Oligomeric compounds for the modulation of HIF-1A expression Charlotte Albaek Thrue, Anja Molhart Hog 2014-07-22
8357670 Oligomeric compounds for the modulation of HIF-1A expression Charlotte Albaek Thrue, Anja Molhart Hog 2013-01-22
8207140 Oligomeric compounds for the modulation of HIF-1α expression Charlotte Albaek Thrue, Anja Molhart Hog 2012-06-26
7906515 Cancer treatment with topoisomerase-II inhibitor, a bis-dioxypiperazine and radiation Kenneth Hofland, Maxwell Sehested, Annemette Thougaard, Peter Jensen 2011-03-15
7846911 Oligomeric compounds for the modulation of HIF-1alpha expression Charlotte Albaek Thrue, Anja Molhart Hog 2010-12-07
7737264 Oligomeric compounds for the modulation HIF-1α expression Charlotte Albæk Thrue, Anja Mølhart Høg 2010-06-15
6701171 Method and apparatus for non-invasive detection of angiogenic and anti-angiogenic activity in living tissue Bjørn Quistorff, Michael Kragh 2004-03-02